Skeleton-vasculature chain reaction: a novel insight into the mystery of homeostasis

Abstract

Angiogenesis and osteogenesis are coupled. However, the cellular and molecular regulation of these processes remains to be further investigated. Both tissues have recently been recognized as endocrine organs, which has stimulated research interest in the screening and functional identification of novel paracrine factors from both tissues. This review aims to elaborate on the novelty and significance of endocrine regulatory loops between bone and the vasculature. In addition, research progress related to the bone vasculature, vessel-related skeletal diseases, pathological conditions, and angiogenesis-targeted therapeutic strategies are also summarized. With respect to future perspectives, new techniques such as single-cell sequencing, which can be used to show the cellular diversity and plasticity of both tissues, are facilitating progress in this field. Moreover, extracellular vesicle-mediated nuclear acid communication deserves further investigation. In conclusion, a deeper understanding of the cellular and molecular regulation of angiogenesis and osteogenesis coupling may offer an opportunity to identify new therapeutic targets.

References

[1] Coultas L, Chawengsaksophak K, Rossant J. Endothelial cells and VEGF in vascular development. Nature, 2005, 438: 937-945

[2] Stegen S, Carmeliet G. The skeletal vascular system—breathing life into bone tissue. Bone, 2018, 115: 50-58

[3] Gutterman DD et al. The human microcirculation regulation of flow and Beyond. Circ. Res., 2016, 118: 157-172

[4] Baumgartner-Parzer SM, Waldhäusl WK. The endothelium as a metabolic and endocrine organ: its relation with insulin resistance. Exp. Clin. Endocrinol. Diabetes., 2001, 109: S166-S179

[5] Fukumoto S, Martin TJ. Bone as an endocrine organ. Trends Endocrinol. Metab., 2009, 20: 230-236

[6] Sivaraj KK, Adams RH. Blood vessel formation and function in bone. Development, 2016, 143: 2706-2715

[7] Prisby RD. Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone. J. Endocrinol., 2017, 235: R77-R100

[8] Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature, 2014, 507: 323-328

[9] Filipowska J, Tomaszewski KA, Niedźwiedzki Ł, Walocha JA, Niedźwiedzki T. The role of vasculature in bone development, regeneration and proper systemic functioning. Angiogenesis, 2017, 20: 291-302

[10] Grosso A et al. It takes two to tango: coupling of angiogenesis and osteogenesis for bone regeneration. Front Bioeng. Biotechnol., 2017, 5: 68

[11] Chim SM et al. Angiogenic factors in bone local environment. Cytokine Growth Factor Rev., 2013, 24: 297-310

[12] Lafage-Proust M, Prisby R, Roche B, Vico L. Bone vascularization and remodeling. Jt. Bone Spine, 2010, 77: 521-524

[13] Trueta J, Harrison MH. The normal vascular anatomy of the femoral head in adult man. J. Bone Jt. Surg. Br., 1953, 35-B: 442-461

[14] Trueta J, Morgan JD. The vascular contribution to osteogenesis. I. Studies by the injection method. J. Bone Jt. Surg. Br., 1960, 42-B: 97-109

[15] Tomlinson RE, Silva MJ. Skeletal blood flow in bone repair and maintenance. Bone Res., 2013, 1: 311-322

[16] Watson EC, Adams RH. Biology of bone: the vasculature of the skeletal system. Cold Spring Harb. Perspect. Med., 2018, 8: a031559

[17] Johnson EO, Soultanis K, Soucacos PN. Vascular anatomy and microcirculation of skeletal zones vulnerable to osteonecrosis: vascularization of the femoral head. Orthopedic Clin. North Am., 2004, 35: 285-291

[18] Ramasamy SK. Structure and functions of blood vessels and vascular niches in bone. Stem Cells Int., 2017, 2017: 1-10

[19] Simpson AH. The blood supply of the periosteum. J. Anat., 1985, 140: 697-704

[20] Blumer MJ, Longato S, Fritsch H. Structure, formation and role of cartilage canals in the developing bone. Ann. Anat., 2008, 190: 305-315

[21] Ramasamy SK et al. Blood flow controls bone vascular function and osteogenesis. Nat. Commun., 2016, 7: 13601

[22] Gurkan UA, Akkus O. The mechanical environment of bone marrow: a review. Ann. Biomed. Eng., 2008, 36: 1978-1991

[23] Grüneboom A et al. Next-generation imaging of the skeletal system and its blood supply. Nat. Rev. Rheumatol., 2019, 15: 533-549

[24] Grüneboom A et al. A network of trans-cortical capillaries as mainstay for blood circulation in long bones. Nat. Metab., 2019, 1: 236-250

[25] Lassen NE et al. Coupling of bone resorption and formation in real time: new knowledge gained from human haversian BMUs. J. Bone Miner. Res., 2017, 32: 1395-1405

[26] Augustin HG, Koh GY. Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology. Science, 2017, 357: eaal2379

[27] Clemency B et al. Intravenous vs. intraosseous access and return of spontaneous circulation during out of hospital cardiac arrest. Am. J. Emerg. Med., 2017, 35: 222-226

[28] Rafii S, Butler JM, Ding B. Angiocrine functions of organ-specific endothelial cells. Nature, 2016, 529: 316-325

[29] Jambusaria A et al. Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation. Elife, 2020, 9: e51413

[30] Reiterer M, Branco CM. Endothelial cells and organ function: applications and implications of understanding unique and reciprocal remodelling. FEBS J., 2020, 287: 1088-1100

[31] Yau JW, Teoh H, Verma S. Endothelial cell control of thrombosis. BMC Cardiovasc. Disord., 2015, 15: 130

[32] Vestweber D. How leukocytes cross the vascular endothelium. Nat. Rev. Immunol., 2015, 15: 692-704

[33] Kruger-Genge A, Blocki A, Franke RP, Jung F. Vascular endothelial cell biology: an update. Int. J Mol. Sci., 2019, 20: 4411

[34] Ramasamy SK, Kusumbe AP, Adams RH. Regulation of tissue morphogenesis by endothelial cell-derived signals. Trends Cell Biol., 2015, 25: 148-157

[35] Marcu R et al. Human organ-specific endothelial cell heterogeneity. iScience, 2018, 4: 20-35

[36] Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von willebrand factor, and Fli-1 in normal human tissues. J. Histochem. Cytochem., 2006, 54: 385-395

[37] Nolan DJ et al. Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. Dev. Cell, 2013, 26: 204-219

[38] Potente M, Mäkinen T. Vascular heterogeneity and specialization in development and disease. Nat. Rev. Mol. Cell Biol., 2017, 18: 477-494

[39] Langen UH et al. Cell–matrix signals specify bone endothelial cells during developmental osteogenesis. Nat. Cell Biol., 2017, 19: 189-201

[40] Wang J et al. CD31hiEmcnhi vessels support new trabecular bone formation at the frontier growth area in the bone defect repair process. Sci. Rep., 2017, 7: 4990

[41] Romeo SG et al. Endothelial proteolytic activity and interaction with non-resorbing osteoclasts mediate bone elongation. Nat. Cell Biol., 2019, 21: 430-441

[42] Sá Da Bandeira D, Casamitjana J, Crisan M. Pericytes, integral components of adult hematopoietic stem cell niches. Pharmacol. Ther., 2017, 171: 104-113

[43] Ding L, Saunders TL, Enikolopov G, Morrison SJ. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature, 2012, 481: 457-462

[44] Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity, 2006, 25: 977-988

[45] Mendelson A, Frenette PS. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat. Med., 2014, 20: 833-846

[46] Poulos MG et al. Endothelial-specific inhibition of NF-κB enhances functional haematopoiesis. Nat. Commun., 2016, 7: 13829

[47] Sivan U, De Angelis J, Kusumbe AP. Role of angiocrine signals in bone development, homeostasis and disease. Open Biol., 2019, 9: 190144

[48] Ramasamy SK, Kusumbe AP, Wang L, Adams RH. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature, 2014, 507: 376-380

[49] Itkin T et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature, 2016, 532: 323-328

[50] Chiu J, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol. Rev., 2011, 91: 327-387

[51] Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell and more. Endocr. Rev., 2013, 34: 658-690

[52] Han Y, You X, Xing W, Zhang Z, Zou W. Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res., 2018, 6: 16

[53] Maes C. Role and regulation of vascularization processes in endochondral bones. Calcif. Tissue Int., 2013, 92: 307-323

[54] Carulli C, Innocenti M, Brandi ML. Bone vascularization in normal and disease conditions. Front. Endocrinol., 2013, 4: 106

[55] Pohlman TH, Harlan JM. Adaptive responses of the endothelium to stress. J. Surg. Res., 2000, 89: 85-119

[56] Gerritsen ME, Bloor CM. Endothelial cell gene expression in response to injury. FASEB J., 1993, 7: 523-532

[57] Grcevic D et al. In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells, 2012, 30: 187-196

[58] Wang RN et al. Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis., 2014, 1: 87-105

[59] Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J., 2011, 11: 471-491

[60] Bostrom K et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest., 1993, 91: 1800-1809

[61] Bouletreau PJ et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast. Reconstr. Surg., 2002, 109: 2384-2397

[62] Kamiya N, Mishina Y. New insights on the roles of BMP signaling in bone-A review of recent mouse genetic studies. Biofactors, 2011, 37: 75-82

[63] Yang W et al. Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells. J. Cell Sci., 2013, 126: 4085-4098

[64] Salazar VS, Gamer LW, Rosen V. BMP signalling in skeletal development, disease and repair. Nat. Rev. Endocrinol., 2016, 12: 203-221

[65] Chen Q et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ., 2016, 23: 1128-1139

[66] Estrada KD et al. Smad7 regulates terminal maturation of chondrocytes in the growth plate. Dev. Biol., 2013, 382: 375-384

[67] Walsh DW, Godson C, Brazil DP, Martin F. Extracellular BMP-antagonist regulation in development and disease: tied up in knots. Trends Cell Biol., 2010, 20: 244-256

[68] Kuchinskaya E et al. Extending the phenotype of BMPER-related skeletal dysplasias to ischiospinal dysostosis. Orphanet J. Rare Dis., 2016, 11: 1

[69] Hellström M et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature, 2007, 445: 776-780

[70] Lawson ND, Siekmann AF. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature, 2007, 445: 781-784

[71] Ridgway J et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature, 2006, 444: 1083-1087

[72] Pitulescu ME et al. Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. Nat. Cell Biol., 2017, 19: 915-927

[73] Choi S et al. BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signaling. Sci. Rep., 2019, 9: 11724

[74] Luo Z et al. Notch signaling in osteogenesis, osteoclastogenesis, and angiogenesis. Am. J. Pathol., 2019, 189: 1495-1500

[75] Engin F et al. Dimorphic effects of Notch signaling in bone homeostasis. Nat. Med., 2008, 14: 299-305

[76] Canalis E, Brunet LJ, Parker K, Zanotti S. Conditional Inactivation of Noggin in the Postnatal Skeleton Causes Osteopenia. Endocrinology, 2012, 153: 1616-1626

[77] Walsh MC, Choi Y. Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond. Front. Immunol., 2014, 5: 511

[78] Chang J et al. Inhibition of osteoblastic bone formation by nuclear factor-κB. Nat. Med., 2009, 15: 682-689

[79] Rochette L et al. The role of osteoprotegerin in the crosstalk between vessels and bone: its potential utility as a marker of cardiometabolic diseases. Pharmacol. Ther., 2018, 182: 115-132

[80] Collin-Osdoby P et al. Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J. Biol. Chem., 2001, 276: 20659-20672

[81] Rochette L et al. The role of osteoprotegerin and its ligands in vascular function. Int. J. Mol. Sci., 2019, 20: 705

[82] Kim HH et al. RANKL regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. FASEB J., 2003, 17: 2163-2165

[83] Potente M, Carmeliet P. The link between angiogenesis and endothelial metabolism. Annu. Rev. Physiol., 2017, 79: 43-66

[84] Kolodkin AL, Matthes DJ, Goodman CS. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell, 1993, 75: 1389-1399

[85] Jongbloets BC, Pasterkamp RJ. Semaphorin signalling during development. Development, 2014, 141: 3292-3297

[86] Alto LT, Terman JR. Semaphorins and their signaling mechanisms. Methods Mol. Biol., 2017, 1493: 1-25

[87] Verlinden L, Vanderschueren D, Verstuyf A. Semaphorin signaling in bone. Mol. Cell. Endocrinol., 2016, 432: 66-74

[88] Gu C, Giraudo E. The role of semaphorins and their receptors in vascular development and cancer. Exp. Cell Res., 2013, 319: 1306-1316

[89] Li Z et al. The role of semaphorin 3A in bone remodeling. Front. Cell. Neurosci., 2017, 11: 40

[90] Kang S, Kumanogoh A. Semaphorins in bone development, homeostasis, and disease. Semin. Cell Develop. Biol., 2013, 24: 163-171

[91] Hayashi M et al. Osteoprotection by semaphorin 3A. Nature, 2012, 485: 69-74

[92] Gomez C et al. Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation. Dev. Dyn., 2005, 234: 393-403

[93] Serini G et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature, 2003, 424: 391-397

[94] Plein A, Fantin A, Ruhrberg C. Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability. Microcirculation, 2014, 21: 315-323

[95] Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur. Heart J., 2012, 33: 829-837

[96] Kalyanaraman H, Schall N, Pilz RB. Nitric oxide and cyclic GMP functions in bone. Nitric Oxide, 2018, 76: 62-70

[97] Veeriah V et al. Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk. Sci. Rep., 2016, 6: 29880

[98] Wimalawansa SJ. Nitric oxide and bone. Ann. N. Y. Acad. Sci., 2010, 1192: 391-403

[99] Jabbour HN, Sales KJ. Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol. Metab., 2004, 15: 398-404

[100] Blackwell KA, Raisz LG, Pilbeam CC. Prostaglandins in bone: bad cop, good cop? Trends Endocrinol. Metab., 2010, 21: 294-301

[101] Lisowska B, Kosson D, Domaracka K. Lights and shadows of NSAIDs in bone healing: the role of prostaglandins in bone metabolism. Drug Des. Devel. Ther., 2018, 12: 1753-1758

[102] Tang SY et al. Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice. Circulation, 2014, 129: 1761-1769

[103] Agas D, Marchetti L, Hurley MM, Sabbieti MG. Prostaglandin F2α: a bone remodeling mediator. J. Cell Physiol., 2013, 228: 25-29

[104] Mirsaidi A, Tiaden AN, Richards PJ. Prostaglandin E2 inhibits matrix mineralization by human bone marrow stromal cell-derived osteoblasts via Epac-dependent cAMP signaling. Sci. Rep., 2017, 7: 2243

[105] Clarkin CE, Emery RJ, Pitsillides AA, Wheeler-Jones CP. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J. Cell Physiol., 2008, 214: 537-544

[106] Chen H et al. Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis. Nat. Commun., 2019, 10: 181

[107] Bernard NJ. Sensing bone mass. Nat. Rev. Rheumatol., 2019, 15: 128

[108] Hu B et al. Sensory nerves regulate mesenchymal stromal cell lineage commitment by tuning sympathetic tones. J. Clin. Invest., 2020, 130: 3483-3498

[109] Chen J, Eltzschig HK, Fredholm BB. Adenosine receptors as drug targets — what are the challenges? Nat. Rev. Drug Discov., 2013, 12: 265-286

[110] Bahreyni A et al. Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives. J. Pharm. Pharmacol., 2018, 70: 191-196

[111] Le GY, Essackjee HC, Ballard HJ. Intracellular adenosine formation and release by freshly-isolated vascular endothelial cells from rat skeletal muscle: effects of hypoxia and/or acidosis. Biochem. Biophys. Res. Commun., 2014, 450: 93-98

[112] Riddle RC, Clemens TL. Bone cell bioenergetics and skeletal energy homeostasis. Physiol. Rev., 2017, 97: 667-698

[113] Lemma S et al. Energy metabolism in osteoclast formation and activity. Int. J. Biochem. Cell Biol., 2016, 79: 168-180

[114] Stovall KE. Adenosine triphosphate enhances osteoblast differentiation of rat dental pulp stem cells via the PLC-IP3 pathway and intracellular Ca²⁺ signaling. J. Cell Physiol., 2020, 235: 1723-1732

[115] Khayat MT, Nayeem MA. The role of adenosine A_2a Receptor, CYP450s, and PPARs in the regulation of vascular tone. Biomed. Res. Int., 2017, 2017: 1-13

[116] Sorrelle N, Dominguez ATA, Brekken RA. From top to bottom: midkine and pleiotrophin as emerging players in immune regulation. J. Leukoc. Biol., 2017, 102: 277-286

[117] Himburg HA et al. Pleiotrophin regulates the retention and self-renewal of hematopoietic stem cells in the bone marrow vascular niche. Cell Rep., 2012, 2: 964-975

[118] Yang X et al. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering. J. Bone Miner. Res., 2003, 18: 47-57

[119] Lamprou M, Kaspiris A, Panagiotopoulos E, Giannoudis PV, Papadimitriou E. The role of pleiotrophin in bone repair. Injury, 2014, 45: 1816-1823

[120] Weiss S, Zimmermann G, Pufe T, Varoga D, Henle P. The systemic angiogenic response during bone healing. Arch. Orthop. Trauma Surg., 2009, 129: 989-997

[121] Palmieri D, Mura M, Mambrini S, Palombo D. Effects of Pleiotrophin on endothelial and inflammatory cells: pro-angiogenic and anti-inflammatory properties and potential role for vascular bio-prosthesis endothelialization. Adv. Med. Sci., 2015, 60: 287-293

[122] Héroult M et al. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. Oncogene, 2004, 23: 1745-1753

[123] Rutkovskiy A, Stensløkken K, Vaage IJ. Osteoblast differentiation at a glance. Med. Sci. Monit. Basic Res., 2016, 22: 95-106

[124] DiGirolamo DJ, Clemens TL, Kousteni S. The skeleton as an endocrine organ. Nat. Rev. Rheumatol., 2012, 8: 674-683

[125] Oldknow KJ, MacRae VE, Farquharson C. Endocrine role of bone: recent and emerging perspectives beyond osteocalcin. J. Endocrinol., 2015, 225: R1-R19

[126] Yin T. The stem cell niches in bone. J. Clin. Invest., 2006, 116: 1195-1201

[127] Patti A, Gennari L, Merlotti D, Dotta F, Nuti R. Endocrine actions of osteocalcin. Int. J. Endocrinol., 2013, 2013: 1-10

[128] Moser SC, van der Eerden BCJ. Osteocalcin-A versatile bone-derived hormone. Front. Endocrinol., 2018, 9: 794

[129] Lee NK et al. Endocrine regulation of energy metabolism by the skeleton. Cell, 2007, 130: 456-469

[130] Mera P et al. Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab., 2016, 23: 1078-1092

[131] Tangseefa P et al. Osteocalcin-dependent regulation of glucose metabolism and fertility: skeletal implications for the development of insulin resistance. J. Cell. Physiol., 2018, 233: 3769-3783

[132] Oury F et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell, 2013, 155: 228-241

[133] Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J. Cell. Physiol., 2013, 228: 1149-1153

[134] Gundberg CM, Lian JB, Booth SL. Vitamin K-dependent carboxylation of osteocalcin: Friend or Foe? Adv. Nutr., 2012, 3: 149-157

[135] Ferron M, Wei J, Yoshizawa T, Ducy P, Karsenty G. An ELISA-based method to quantify osteocalcin carboxylation in mice. Biochem. Biophys. Res. Commun., 2010, 397: 691-696

[136] Millar SA, Anderson SI, O’Sullivan SE. Osteokines and the vasculature: a review of the in vitro effects of osteocalcin, fibroblast growth factor-23 and lipocalin-2. PeerJ, 2019, 7: e7139

[137] Millar SA et al. Vascular calcification, and atherosclerosis: a systematic review and meta-analysis. Front. Endocrinol., 2017, 8: 183

[138] Tacey A et al. Potential role for osteocalcin in the development of atherosclerosis and blood vessel disease. Nutrients, 2018, 10: 1426

[139] Fredriksson L, Li H, Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev., 2004, 15: 197-204

[140] Cao R et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat. Med, 2003, 9: 604-613

[141] Xie H et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat. Med., 2014, 20: 1270-1278

[142] Gao B et al. Macrophage-lineage TRAP⁺ cells recruit periosteum-derived cells for periosteal osteogenesis and regeneration. J. Clin. Invest., 2019, 130: 2578-2594

[143] Su W et al. Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development. JCI Insight, 2020, 5: e135446

[144] Yang P et al. Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice. Bone, 2018, 114: 1-13

[145] Wang H et al. Over-expression of PDGFR-β promotes PDGF-induced proliferation, migration, and angiogenesis of EPCs through PI3K/Akt signaling pathway. PLoS ONE, 2012, 7: e30503

[146] Jaworski A, Tessier-Lavigne M. Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. Nat. Neurosci., 2012, 15: 367-369

[147] Rama N et al. Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization. Nat. Med., 2015, 21: 483-491

[148] Zhou W, Geng ZH, Spence JR, Geng J. Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection. Nature, 2013, 501: 107-111

[149] Mehlen P, Delloye-Bourgeois C, Chédotal A. Novel roles for Slits and netrins: axon guidance cues as anticancer targets? Nat. Rev. Cancer, 2011, 11: 188-197

[150] Paul JD et al. SLIT3–ROBO4 activation promotes vascular network formation in human engineered tissue and angiogenesis in vivo. J. Mol. Cell. Cardiol., 2013, 64: 124-131

[151] Xu R et al. Targeting skeletal endothelium to ameliorate bone loss. Nat. Med., 2018, 24: 823-833

[152] Kim BJ et al. Osteoclast-secreted SLIT3 coordinates bone resorption and formation. J. Clin. Invest., 2018, 128: 1429-1441

[153] Li N et al. Osteoclasts are not a source of SLIT3. Bone Res, 2020, 8: 11

[154] Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell, 2019, 176: 1248-1264

[155] Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat. Rev. Mol. Cell Biol., 2016, 17: 611-625

[156] Eelen G et al. Endothelial cell metabolism. Physiol. Rev., 2018, 98: 3-58

[157] Maes C et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J. Clin. Invest., 2004, 113: 188-199

[158] Haigh K et al. Increased skeletal VEGF enhances β-catenin activity and results in excessively ossified bones. EMBO J., 2010, 29: 424-441

[159] Gerber HP et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med, 1999, 5: 623-628

[160] Schipani E, Maes C, Carmeliet G, Semenza GL. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J. Bone Miner. Res., 2009, 24: 1347-1353

[161] Wang Y et al. The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development. J. Clin. Invest., 2007, 117: 1616-1626

[162] Hu K, Olsen BR. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J. Clin. Invest., 2016, 126: 509-526

[163] Latko M et al. Cross-talk between fibroblast growth factor receptors and other cell surface proteins. Cells, 2019, 8: 455

[164] Takashi Y, Fukumoto S. FGF23 beyond phosphotropic hormone. Trends Endocrinol Metab., 2018, 29: 755-767

[165] Kozhemyakina E, Lassar AB, Zelzer E. A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development, 2015, 142: 817-831

[166] Behr B, Leucht P, Longaker MT, Quarto N. Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. Proc. Natl Acad. Sci. USA, 2010, 107: 11853-11858

[167] Calvi LM. Osteolineage cells and regulation of the hematopoietic stem cell. Best. Pract. Res. Clin. Haematol., 2013, 26: 249-252

[168] Richter B, Faul C. FGF23 actions on target tissues-with and without klotho. Front. Endocrinol, 2018, 9: 189

[169] Auguste P, Javerzat S, Bikfalvi A. Regulation of vascular development by fibroblast growth factors. Cell Tissue Res., 2003, 314: 157-166

[170] Yu P et al. FGF-dependent metabolic control of vascular development. Nature, 2017, 545: 224-228

[171] Le B et al. The components of bone and what they can teach us about regeneration. Materials, 2018, 11: 14

[172] Alford AI, Kozloff KM, Hankenson KD. Extracellular matrix networks in bone remodeling. Int. J. Biochem. Cell Biol., 2015, 65: 20-31

[173] Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J. Enzym. Inhib. Med. Chem., 2016, 31: S177-S183

[174] Lemaître V, D’Armiento J. Matrix metalloproteinases in development and disease. Birth Defects Res. C Embryo Today, 2006, 78: 1-10

[175] Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol., 2014, 15: 786-801

[176] Sang QX. Complex role of matrix metalloproteinases in angiogenesis. Cell Res., 1998, 8: 171-177

[177] Fields GB. Mechanisms of action of novel drugs targeting angiogenesis-promoting matrix metalloproteinases. Front. Immunol., 2019, 10: 1278

[178] Ortega N, Wang K, Ferrara N, Werb Z, Vu TH. Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation. Dis. models Mech., 2010, 3: 224-235

[179] Sun C et al. Up-regulated expression of matrix metalloproteinases in endothelial cells mediates platelet microvesicle-induced angiogenesis. Cell. Physiol. Biochem., 2017, 41: 2319-2332

[180] Colnot C. Altered fracture repair in the absence of MMP9. Development, 2003, 130: 4123-4133

[181] Cackowski FC et al. Osteoclasts are important for bone angiogenesis. Blood, 2010, 115: 140-149

[182] Neve A, Cantatore FP, Maruotti N, Corrado A, Ribatti D. Extracellular matrix modulates angiogenesis in physiological and pathological conditions. Biomed. Res. Int., 2014, 2014: 756078

[183] Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood, 1994, 83: 799-807

[184] Mosialou I et al. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature, 2017, 543: 385-390

[185] Abella V et al. The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers, 2016, 20: 565-571

[186] Wang Y. Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2. Br. J. Pharmacol., 2012, 165: 603-621

[187] Yndestad A et al. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure. Eur. Heart J., 2009, 30: 1229-1236

[188] Liu JT et al. Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition. Br. J. Pharmacol., 2012, 165: 520-531

[189] Amersfoort J et al. Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner. Atherosclerosis, 2018, 275: 214-224

[190] Wu C, Giaccia AJ, Rankin EB. Osteoblasts: a novel source of erythropoietin. Curr. Osteoporos. Rep., 2014, 12: 428-432

[191] Acar M et al. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature, 2015, 526: 126-130

[192] Kiel MJ et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell, 2005, 121: 1109-1121

[193] Ramasamy SK et al. Regulation of hematopoiesis and osteogenesis by blood vessel-derived signals. Annu. Rev. Cell Dev. Biol., 2016, 32: 649-675

[194] Zhu S et al. Endothelial cells produce angiocrine factors to regulate bone and cartilage via versatile mechanisms. Theranostics, 2020, 10: 5957-5965

[195] Kusumbe AP et al. Age-dependent modulation of vascular niches for haematopoietic stem cells. Nature, 2016, 532: 380-384

[196] Taichman RS, Emerson SG. The role of osteoblasts in the hematopoietic microenvironment. Stem Cells, 1998, 16: 7-15

[197] Yu Y et al. EPO could be regulated by HIF-1 and promote osteogenesis and accelerate bone repair. Artif. Cells Nanomed. Biotechnol., 2020, 48: 206-217

[198] Rankin EB et al. The HIF signaling pathway in osteoblasts directly modulates erythropoiesis through the production of EPO. Cell, 2012, 149: 63-74

[199] Visnjic D et al. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood, 2004, 103: 3258-3264

[200] Peschon JJ et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med, 1994, 180: 1955-1960

[201] Percival CJ, Richtsmeier JT. Angiogenesis and intramembranous osteogenesis. Dev. Dyn., 2013, 242: 909-922

[202] Winet H. The role of microvasculature in normal and perturbed bone healing as revealed by intravital microscopy. Bone, 1996, 19: S39-S57

[203] Berger R. Aging in America: ageism and general attitudes toward growing old and the elderly. Open J. Soc. Sci., 2017, 5: 183-198

[204] Khosla S, Farr JN, Tchkonia T, Kirkland JL. The role of cellular senescence in ageing and endocrine disease. Nat. Rev. Endocrinol., 2020, 16: 263-275

[205] Sommerfeldt D, Rubin C. Biology of bone and how it orchestrates the form and function of the skeleton. Eur. Spine J., 2001, 10: S86-S95

[206] Wang L et al. Human type H vessels are a sensitive biomarker of bone mass. Cell Death Dis., 2017, 8

[207] Chambers SM et al. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol., 2007, 5

[208] Yang T et al. A road map for understanding molecular and genetic determinants of osteoporosis. Nat. Rev. Endocrinol., 2020, 16: 91-103

[209] Ji M, Yu Q. Primary osteoporosis in postmenopausal women. Chronic Dis. Transl. Med., 2015, 1: 9-13

[210] Eastell R et al. Postmenopausal osteoporosis. Nat. Rev. Dis. Primers, 2016, 2: 16069

[211] Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J. Bone Miner. Res., 1997, 12: 283-289

[212] Peng Y et al. Glucocorticoids disrupt skeletal angiogenesis through transrepression of NF-kappaB-mediated preosteoclast Pdgfb transcription in young mice. J. Bone Miner. Res., 2020, 35: 1188-1202

[213] Weinstein RS. Glucocorticoids, osteocytes, and skeletal fragility: the role of bone vascularity. Bone, 2010, 46: 564-570

[214] Chen D et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res., 2017, 5: 16044

[215] Cui Z et al. Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone. Ann. Rheum. Dis., 2016, 75: 1714-1721

[216] Lu J et al. Positive-feedback regulation of subchondral H-type vessel formation by chondrocyte promotes osteoarthritis development in mice. J. Bone Miner. Res., 2018, 33: 909-920

[217] Zhu S et al. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J. Clin. Invest., 2019, 129: 1076-1093

[218] MacDonald IJ et al. Implications of angiogenesis involvement in arthritis. Int. J. Mol. Sci., 2018, 19: 2012

[219] Zura R, Mehta S, Della Rocca GJ, Steen RG. Biological risk factors for nonunion of bone fracture. JBJS Rev., 2016, 4: e2

[220] Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N. Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management. Endocr. Rev., 2019, 40: 333-368

[221] Cummings SR, Eastell R. Risk and prevention of fracture in patients with major medical illnesses: a mini-review. J. Bone Miner. Res., 2016, 31: 2069-2072

[222] Marsell R, Einhorn TA. The biology of fracture healing. Injury, 2011, 42: 551-555

[223] Saran U, Gemini PS, Chatterjee S. Role of angiogenesis in bone repair. Arch. Biochem. Biophys., 2014, 561: 109-117

[224] Stegen S, van Gastel N, Carmeliet G. Bringing new life to damaged bone: the importance of angiogenesis in bone repair and regeneration. Bone, 2015, 70: 19-27

[225] Murnaghan M, Li G, Marsh DR. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis? J. Bone Jt. Surg. Am., 2006, 88: S140-S147

[226] Marenzana M, Arnett TR. The key role of the blood supply to bone. Bone Res, 2013, 1: 203-215

[227] Street J et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl Acad. Sci. USA, 2002, 99: 9656-9661

[228] Lafforgue P. Pathophysiology and natural history of avascular necrosis of bone. Jt. Bone Spine, 2006, 73: 500-507

[229] Kerachian MA, Harvey EJ, Cournoyer D, Chow TYK, Séguin C. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium, 2009, 13: 237-244

[230] Reid IR, Cornish J. Epidemiology and pathogenesis of osteonecrosis of the jaw. Nat. Rev. Rheumatol., 2011, 8: 90-96

[231] Pouya F, Kerachian MA. Avascular necrosis of the femoral head: are any genes involved? Arch. Bone Jt Surg., 2015, 3: 149-155

[232] Feng Y et al. Decreased in the number and function of circulation endothelial progenitor cells in patients with avascular necrosis of the femoral head. Bone, 2010, 46: 32-40

[233] Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocrine, 2012, 41: 183-190

[234] Grieb TA et al. High-dose gamma irradiation for soft tissue allografts: high margin of safety with biomechanical integrity. J. Orthop. Res., 2006, 24: 1011-1018

[235] Meyers C et al. Heterotopic ossification: a comprehensive review. JBMR Plus, 2019, 3: e10172

[236] Cocks M et al. Vascular patterning in human heterotopic ossification. Hum. Pathol., 2017, 63: 165-170

[237] Hwang C et al. Mesenchymal VEGFA induces aberrant differentiation in heterotopic ossification. Bone Res., 2019, 7: 36

[238] Fuery MA, Liang L, Kaplan FS, Mohler ER. Vascular ossification: pathology, mechanisms, and clinical implications. Bone, 2018, 109: 28-34

[239] Prisby RD. Bone marrow blood vessel ossification and “microvascular dead space” in rat and human long bone. Bone, 2014, 64: 195-203

[240] DeFronzo RA et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers, 2015, 1: 15019

[241] Shanbhogue VV, Hansen S, Frost M, Brixen K, Hermann AP. Bone disease in diabetes: another manifestation of microvascular disease? Lancet Diabetes Endocrinol., 2017, 5: 827-838

[242] Sellmeyer DE et al. Skeletal metabolism, fracture risk, and fracture outcomes in Type 1 and Type 2 diabetes. Diabetes, 2016, 65: 1757-1766

[243] Wang A, Midura RJ, Vasanji A, Wang AJ, Hascall VC. Hyperglycemia diverts dividing osteoblastic precursor cells to an adipogenic pathway and induces synthesis of a hyaluronan matrix that is adhesive for monocytes. J. Biol. Chem., 2014, 289: 11410-11420

[244] Stabley JN, Prisby RD, Behnke BJ, Delp MD. Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat. J. Endocrinol., 2015, 225: 47-58

[245] Yamagishi S, Nakamura N, Suematsu M, Kaseda K, Matsui T. Advanced glycation end products: a molecular target for vascular complications in diabetes. Mol. Med., 2015, 21: S32-S40

[246] Schalkwijk CG, Stehouwer CDA. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin. Sci., 2005, 109: 143-159

[247] Mangialardi G et al. Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway. Arterioscler. Thromb. Vasc. Biol., 2013, 33: 555-564

[248] Suva LJ, Washam C, Nicholas RW, Griffin RJ. Bone metastasis: mechanisms and therapeutic opportunities. Nat. Rev. Endocrinol., 2011, 7: 208-218

[249] Butler JM, Rafii S, Kobayashi H. Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors. Nat. Rev. Cancer, 2010, 10: 138-146

[250] Kusumbe AP. Vascular niches for disseminated tumour cells in bone. J. Bone Oncol., 2016, 5: 112-116

[251] Virk MS, Lieberman JR. Tumor metastasis to bone. Arthritis Res. Ther., 2007, 9: S5

[252] Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature, 2000, 407: 249-257

[253] Singh A et al. Angiocrine signals regulate quiescence and therapy resistance in bone metastasis. JCI Insight, 2019, 4: e125679

[254] Méndez-Ferrer S et al. Bone marrow niches in haematological malignancies. Nat. Revi. Cancer, 2020, 20: 285-298

[255] Duarte D et al. Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML. Cell Stem Cell, 2018, 22: 64-77

[256] Ceci C, Atzori MG, Lacal PM, Graziani G. Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models. Int. J. Mol. Sci., 2020, 21: 1388

[257] Recasens A, Munoz L. Targeting cancer cell dormancy. Trends Pharmacol. Sci., 2019, 40: 128-141

[258] Huang J et al. Harmine enhances type H vessel formation and prevents bone loss in ovariectomized mice. Theranostics, 2018, 8: 2435-2446

[259] Stiers P, van Gastel N, Carmeliet G. Targeting the hypoxic response in bone tissue engineering: a balance between supply and consumption to improve bone regeneration. Mol. Cell. Endocrinol., 2016, 432: 96-105

[260] Chen M, Zhang Y, Zhang W, Li JA. Polyhedral oligomeric silsesquioxane (POSS)-incorporated gelatin hydrogel promotes angiogenesis during vascularized bone regeneration. ACS Appl. Mater. Interfaces, 2020, 12: 22410-22425

[261] Mercado-Pagán ÁE, Stahl AM, Shanjani Y, Yang Y. Vascularization in bone tissue engineering constructs. Ann. Biomed. Eng., 2015, 43: 718-729

[262] Wei J et al. Guided self-generation of vascularized neo-bone for autologous reconstruction of large mandibular defects. J. Craniofacial Surg., 2016, 27: 958-962

[263] Bonfield W. Designing porous scaffolds for tissue engineering. Philos. Trans. A Math. Phys. Eng. Sci., 2006, 364: 227-232

[264] Liang Y et al. Endothelial progenitors enhanced the osteogenic capacities of mesenchymal stem cells in vitro and in a rat alveolar bone defect model. Arch. Oral. Biol., 2016, 68: 123-130

[265] Shapiro G, Lieber R, Gazit D, Pelled G. Recent advances and future of gene therapy for bone regeneration. Curr. Osteoporos. Rep., 2018, 16: 504-511

[266] Yang M et al. MiR-497∼195 cluster regulates angiogenesis during coupling with osteogenesis by maintaining endothelial Notch and HIF-1α activity. Nat. Commun., 2017, 8

[267] Fu R et al. Endothelial ZEB1 promotes angiogenesis-dependent bone formation and reverses osteoporosis. Nat. Commun., 2020, 11: 460

[268] Sun X et al. Current progress on microRNA-based gene delivery in the treatment of osteoporosis and osteoporotic fracture. Int. J. Endocrinol., 2019, 2019: 1-17

[269] Lafage-Proust M et al. Assessment of bone vascularization and its role in bone remodeling. Bonekey Rep., 2015, 4: 662

[270] Liu Y, Luo D, Wang T. Hierarchical structures of bone and bioinspired bone tissue engineering. Small, 2016, 12: 4611-4632

[271] Materka PC, Tuliszkiewicz J. Texture analysis of x-ray images for detection of changes in bone mass and structure. Texture Anal. Mach. Vis., 2000, 40: 189-195

[272] Eberwine J, Sul J, Bartfai T, Kim J. The promise of single-cell sequencing. Nat. methods, 2014, 11: 25-27

[273] Chappell L, Russell A, Voet T. Single-Cell (Multi)omics Technologies. Annu. Rev. Genomics Hum. Genet., 2018, 19: 15-41

[274] Ortega MA et al. Using single-cell multiple omics approaches to resolve tumor heterogeneity. Clin. Transl. Med., 2017, 6: 46

[275] Turner AW et al. Multi-omics approaches to study long non-coding RNA function in atherosclerosis. Front Cardiovasc Med, 2019, 6: 9

[276] Buescher JM, Driggers EM. Integration of omics: more than the sum of its parts. Cancer Metab., 2016, 4: 4

[277] Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell, 2016, 164: 1226-1232

[278] Yin P et al. Exchange of genetic material: a new paradigm in bone cell communications. Cell. Mol. Life Sci., 2018, 75: 1989-1998

[279] Song H et al. Reversal of osteoporotic activity by endothelial cell-secreted bone-targeting and biocompatible exosomes. Nano Lett., 2019, 19: 3040-3048

[280] Housden BE et al. Loss-of-function genetic tools for animal models: cross-species and cross-platform differences. Nat. Rev. Genet., 2017, 18: 24-40

Funding

National Natural Science Foundation of China (National Science Foundation of China)(81702176)

École Nationale d'Ingénieurs de Saint-Etienne (National Engineering School of Saint-Étienne)(81702176)